Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

Low-energy sweeteners show no acute effects on postprandial glucose, insulin

04 Nov 2020

Consumption of low-energy sweeteners (LES), alone or in combination with a nutrient-containing preload, appears to have no acute effects on the mean changes in postprandial glycaemic or insulinaemic responses relative to a control intervention, reports a study.

“Apart from a small beneficial effect on postprandial glucose (PPG; −0.3 mmol/L) in studies enrolling patients with type 2 diabetes, the effects did not differ by type or dose of LES, or fasting glucose or insulin levels,” the investigators said.

The databases of Medline, Ovid FSTA, and Scopus were systematically searched until January 2020 for randomized controlled trials comparing acute effects on PPG and/or postprandial insulin (PPI) after exposure to LES, either alone, with a meal, or with other nutrient-containing preloads to the same intervention without LES.

The investigators calculated PPG and PPI responses as mean incremental area under the curve divided by time. Random effects models with inverse variance weighing were used to carry out the meta-analyses.

Twenty-six papers including 34 PPG trials and 29 PPI trials were eligible for meta-analysis. No statistically significant differences were observed in the effects of LES on PPG and PPI responses compared with control interventions. The pooled effects of LES intake on the mean change difference was –0.02 mmol/L (95 percent confidence interval [CI], –0.09 to 0.05) in PPG and –2.39 pmol/L (95 percent CI, –11.83 to 7.05) in PPI.

There was no significant difference in the results regarding type or dose of LES ingested, cointervention type, or fasting glucose and insulin levels. Moreover, the mean change difference among patients with type 2 diabetes indicated a smaller PPG response after LES exposure relative to control (–0.3 mmol/L, 95 percent CI, –0.53 to –0.07).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.